MS research suggests the disease may be divided into two biological subtypes that differ in how early and aggressively nerve ...

The company recently hit significant roadblocks with its BTK inhibitor, but there are plenty of fish in the sea for the drug ...

There may be two distinct subtypes of multiple sclerosis, according to a new study led by scientists at University College ...

Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and safety in diverse patient populations. The MUSETTE trial confirmed that the ...

The immune system's reaction to the common Epstein-Barr virus can ultimately damage the brain and contribute to multiple ...

Other prenatal exposures -- preterm birth (before 37 weeks gestation), placental abruption, and maternal hypertensive ...

Artificial intelligence (AI), using a simple blood test combined with standard brain images has, for the first time, been ...

Multiple sclerosis (MS) is a chronic neurological disease characterized by nerve damage and consequent impairments in vision, ...

Cannabis use may impair the ability of people with multiple sclerosis to accurately self-assess their cognitive performance.

Tiziana's foralumab continues to be safe and well-tolerated, with no drug-related serious side effects after long-term use, ...

Some treatments for multiple sclerosis (MS) help ease day-to-day symptoms, while others can help control an attack (relapse). Other medicines are designed to limit further damage to the nervous system ...

Multiple sclerosis (MS) is a chronic autoimmune disorder of the central nervous system (CNS), including the brain, spinal cord, and optic nerves. The body mistakenly attacks and damages the protective ...